A clinical trial included twenty-one normotensive patients with microalbuminuria demonstrated that combined human C-peptide (600 nmol/24 h) and insulin administration for 3 months might improve the kidney function by decreasing the urinary albumin excretion in patients with type 1 diabetes mellitus (24). Here, ALB is linked to type 1 diabetes mellitus.